Regional cerebral blood flow changes in patients with cirrhosis assessed with 99mTc-HM-PAO single-photon emission computed tomography: Effect of liver transplantation

Journal of Hepatology

Volumn 29, Issue 1, 1998, Pages 78-84

  Dam, Mauro ^a   Burra, Patrizia ^b   Tedeschi, Umberto ^b   Cagnin, Annachiara ^b   Chierichetti, Franca ^b   Ermani, Mario ^b   Ferlin, Giorgio ^b   Naccarato, Remo ^b   Pizzolato, Gilberto ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b NONE

Author keywords

99mTc Hexamethylpropyleneamineoxime; Cerebral blood flow; Liver cirrhosis; Liver transplantation; Single photon emission computed tomography

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0032125434     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80181-5     Document Type: Article

References (38)

1. Gilberstadt SJ, Gilberstadt H, Zieve L, Beugel B, Collier RO, McClain CJ. Psychomotor performance defects in cirrhotic patients without overt encephalopathy. Arch Intern Med. 140:1980;519-521.
2. Gitlin N, Lewis DC, Hinkley L. Diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. J Hepatol. 3:1986;75-82.
3. Trzepacz PT, Tarter RE, Shah A, Tringali R, Faett DG, Van Thiel DH. SPECT Scan and cognitive findings in subclinical hepatic encephalopathy. J Neuropsych Clin N. 6:1994;170-175.
4. Moore JW, Dunk AA, Crawford JR, Deans H, Besson JA, De Lacey G, et al. Neuropsychological deficits and morphological MRI brain scan abnormalities in apparently healthy non-encephalopathic patients with cirrhosis. A controlled study. J Hepatol. 9:1989;319-325.
5. Zeneroli ML, Pinelli G, Gollini G, Penne A, Messori E, Zani G, et al. Visual evoked potential: a diagnostic tool for the assessment of hepatic encephalopathy. Gut. 25:1984;291-299.
6. Yang SS, Chu NS, Liaw YF. Somatosensory evoked potentials in hepatic encephalopathy. Gastroenterology. 89:1985;625-630.
7. Yang SS, Chu NS, Liaw YF. Brainstem auditory evoked potentials in hepatic encephalopathy. Hepatology. 6:1986;1352-1355.
8. Mehndiratta MM, Sood GK, Sarin SK, Gupta M. Comparative evaluation of visual, somatosensory, and auditory evoked potentials in detection of subclinical hepatic encephalopathy in patients with nonalcoholic cirrhosis. Am J Gastroenterol. 85:1990;799-803.
9. Guedon C, Ducrotte P, Weber J, Hannequin D, Colin R, Denis P, et al. Detection of subclinical hepatic encephalopathy with pattern reversal evoked potentials and reaction time to light: can malnutrition alter the results? Eur J Gastroenterol Hepatol. 5:1993;549-554.
10. Rodriguez G, Testa R, Celle G, Gris A, Marenco S, Nobili F, et al. Reduction of cerebral blood flow in subclinical hepatic encephalopathy and its correlation with plasma-free tryptophan. J Cereb Blood Flow Metab. 7:1987;768-772.
11. Testa R, Rodriguez G, Arvigo F, Grasso A, Gris A, Nobili F, et al. Cerebral blood flow and plasma-free tryptophan in cirrhotics with and without hepatic encephalopathy. Ital J Neurol Sci. 10:1989;415-421.
12. Lockwood AH, Yap EWH, Rhoades HM, Wong WH. Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy. J Cereb Blood Flow Metab. 11:1991;331-336.
13. O'Carroll RE, Hayes PC, Ebmeier KB, Dougall N, Murray C, Best JJK, et al. Regional cerebral blood flow and cognitive function in patients with chronic liver disease. Lancet. 337:1991;1250-1253.
14. Lockwood AH, Murphy BW, Donnelly KZ, Mahal TC, Perini S. Positron-emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy. Hepatology. 18:1993;1061-1068.
15. Sood GK, Sarin SK, Mahaptra J, Broor SL. Comparative efficacy of psychometric tests in detection of subclinical hepatic encephalopathy in nonalcoholic cirrhotics: search for a rational approach. Am J Gastroenterol. 84:1989;156-159.
16. Lear JL. Initial cerebral HMPAO distribution compared to LCBF: use of a model which considers cerebral HMPAO trapping kinetics. J Cereb Blood Flow Metab. 8:1988;31-37. (suppl 1).
17. 99mTc/DL-HMPAO in human brain after intracarotid bolus injection: a kinetic analysis. J Cereb Blood Flow Metab. 8:1988;13-22. (suppl 1).
18. 99mTc/DL-HMPAO by rapid octanol extraction. J Cereb Blood Flow Metab. 8:1988;23-30. (suppl 1).
19. 99mTc HMPAO compared with regional cerebral blood flow measured by PET: effects of linearization. J Cereb Blood Flow Metab. 8:1988;82-89. (suppl 1).
20. Pugh RNH, Murray-Lion IM, Dawson JL, Pietroni ME, Williams R. Transection of the oesophagus for bleeding varices. Br J Surg. 60:1973;646-649.
21. Conn HO. Assessment of the severity of hepatic encephalopathy. Rodes J, Arroyo V. Therapy in Liver Disease. 1992;277-291 Ediciones Doyma, Barcelona.
22. Parsons-Smith BG, Summerskill WHJ, Dawson AM, Sherlock S. The electroencephalograph in liver disease. Lancet. ii:1957;867-871.
23. Sorensen JA. Qualitative measurement of radioactivity in vivo by whole body counting. Hyne GJ, Sorenson JA. Instrumentation in Nuclear Medicine. 1974;311-324 Academic Press, New York.
24. Talairach J, Tournoux P. Co-planar Stereotaxic Atlas of the Human Brain. 1988;Thieme, Stuttgart.
25. Damasio H, Damasio AR. Lesion Analysis in Neuropsychology. 1989;Oxford University Press, New York.
26. 99mTc-HM-PAO SPECT in Parkinson's disease. J Cereb Blood Flow Metab. 8:1988;101-108. (Suppl).
27. Castell DO, Moore EW. Ammonia absorption from the human colon. The role of non-ionic diffusion. Gastroenterology. 60:1971;33-42.
28. Butterworth RF. The neurobiology of hepatic encephalopathy. Semin Liver Dis. 16:1996;235-244.
29. Cruz NF, Duffy TE. Local cerebral glucose metabolism in rats with chronic portacaval shunts. J Cereb Blood Flow Metab. 3:1983;311-320.
30. Lockwood AH, Ginsberg MD, Rhoades HM, Gutierrez MT. Cerebral glucose metabolism after portacaval shunting in the rat. Patterns of metabolism and implications for the pathogenesis of hepatic encephalopathy. J Clin Invest. 78:1986;86-95.
31. Valmier J, Touchon J, Zanca M, Fauchere V, Bories P, Baldy-Moulinier M. Correlations between cerebral grey matter flow and histology in alcoholism. Eur Neurol. 25:1986;428-435.
32. Pizzolato G, Burra P, Naccarato R, Mantovan C, Cagnin A, Fabbri M, et al. Cortical metabolic deficits in patients with end-stage liver disease without neurological abnormalities: a 18F-fluorodeoxyglucose PET study. [abstract] Neurology. 46:1996;415. (Suppl.).
33. Höckerstedt K, Kajaste S, Muuronen A, Raininko R, Seppalainen AM, Hillbom M. Encephalopathy and neuropathy in end-stage liver disease before and after liver transplantation. J Hepatol. 16:1992;31-37.
34. Samson Y, Baron JC, Feline A, Bories J, Crouzel C. Local cerebral glucose utilization in chronic alcoholics: a positron tomographic study. J Neurol Neurosurg Psych. 49:1986;1165-1170.
35. Gilman S, Adams K, Koeppe RA, Berent S, Kluin KJ, Modell JG, et al. Cerebellar and frontal hypometabolism in alcoholic cerebellar degeneration studied with positron emission tomography. Ann Neurol. 28:1990;775-785.
36. Barthauer L, Tarter R, Hirsch W, Van Thiel DH. Brain morphologic characteristics of cirrhotic alcoholics and cirrhotic non-alcoholics: an MRI study. Alcohol Clin Exp Res. 16:1992;982-985.
37. Fox JH, Ramsey RG, Huckman MS, Proske AE. Cerebral ventricular enlargment in chronic alcoholics examined by computerized tomography. JAMA. 236:1976;365-368.
38. Ron MA. Brain damage in chronic alcoholism: a neuropathological, neuroradiological and psychological review. Psychol Med. 7:1977;103-112.